WMCMA Monthly Meeting

Thursday, February 09, 2017

"Lipid Management and the Role of PCSK9 Inhibition" 1.0 CE

 Presented by Mathew Ito, Pharm D. FCCP, FNLA, CLS 

Regional Medical Liasion, Sanofi, US Medical Affairs.

Past President, National Lipid Association

 TIME:
11:00 a.m. to 1:00 p.m.
 Check-In and Networking 11:00 ~ Buffet Lunch 11:00 ~ Program 11:40 am to 12:50 pm                    Teleconference Call-in at 11:40 am

 
LOCATION:
Lynnwood Convention Center
3711 196th Street SW Lynnwood, WA 98036

COST:
Onsite rate (includes lunch): $20 for members; $30 for non-members

*Members: Early Registration saves you $5! Onsite Only. Discount Ends 01/21/17*

TELECONFERENCE: $10

  Application has been made for pre-approval by The Commission for Case Manager Certification to provide continuing education credit to CCM® board certified case managers for  1.0 CE contact hour(s).* 

PROGRAM DESCRIPTION:

This presentation will focus the new class of PCSK9 inhibitors and the integrated into the management of patients with severe lipid disorders, including Familial Hypercholesterolemia (FH), to help achieve lipid management goals.  

Objectives: 

• Identify the “root cause” of atherosclerosis
• Describe the clinical evidence which support that lower on treatment cholesterol is associated with improved clinical outcomes.
• Compare and contrast the various US lipid management recommendations.
• Summarize LDL receptor recycling and the biology of Proprotein convertase subtilisin/kexin type 9 (PCSK9).
• Describe the mechanism of action, indications, efficacy, and side-effects of alirocumab.

ABOUT OUR SPEAKER:

 Mathew Ito, Pharm. D., FCCP, FNLA, CLS, Regional Medical Liaison for Sanofi, US Medical Affairs and Past-President of the National Lipid Association 

Matthew Ito received his Doctor of Pharmacy degree from the University of Southern California (USC).  He completed a pharmacy practice residency and pharmacokinetics fellowship at USC. He is board certified in clinical lipidology and directed a pharmacist-run lipid clinic for 13 years at the San Diego VA Medical Center while on faculty at the University of the Pacific.  Prior to joining SANOFI, Matt was a Professor and Director of the Cardiovascular Pharmacodynamics Laboratory at the Oregon State University/Oregon Health & Science University College of Pharmacy. He is a Past-President of the National Lipid Association.

Matt resides in the Portland area and has responsibility for the Pacific Northwest.

Please join us for this informative presentation.

REGISTRATION IS REQUIRED:

The Onsite luncheon is limited to 60 attendees. Once the luncheon is full you can still register to listen by teleconference. 

 Online registration is easier than ever!  You can register online whether you are paying by credit card or planning to pay later or sending a check - just click on the "Register Now" button below.  You can also call the WMCMA office at (425) 329-9456 or email contactWMCMA@gmail.com to register.  Reservations must be prepaid or guaranteed by check, VISA, Mastercard, AMEX, or Discover.  Registration deadline is Monday, February 6th 2017.  Please help us by registering early so we have an accurate count for room space and lunches.  The cancellation deadline for this event is Monday, February 6th, 2017. Questions? Contact us at rebekahb.wmcma@gmail.com or contactwmcma@gmail.com.

Register Now!